Clinical Trials Browser

Interventional × INCB039110 × 90 days × Clear all

NCT02917993 2026-02-09

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung, Inhibition, Psychological, Lung Neoplasms, Neoplasm Metastasis

NCT01905813 2025-12-19

Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies

Phase 1 Active not recruiting

B-cell Malignancies